Cells from cancerous tumors can spread, or metastasize, throughout the body. Researchers have long sought to understand what determines where those cells will go and thrive in order to more effectively treat the cancer and prevent metastasis. Researchers at Yale School of Medicine (YSM) have now identified biological markers for a rare, aggressive eye cancer that predict the likelihood of secondary tumors forming in the liver.



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *

Explore More

Eye drops derived from PEDF protein slow vision loss in animal models

Model of PEDF protein alongside the 17-mer and H105A peptides. Amino acid 105, which is changed from histidine in PEDF and the 17-mer peptide to alanine in the H105A peptide,

Use of semaglutide linked to doubled risk of neovascular macular degeneration

Credit: Unsplash/CC0 Public Domain Semaglutide, widely used to treat diabetes and obesity, was associated with more than double the risk of developing neovascular age-related macular degeneration (nAMD) in older patients

Low-dose eye drops can manage adult myopia for 24 hours

Groundbreaking research from the University of Houston shows that a single low-dose atropine eye drop can produce daylong effects in managing myopia, or nearsightedness, which affects roughly one-third of U.S.